Fedratinib
Back to searchMolecule Structure
Scientific Name
Fedratinib
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12500
http://www.drugbank.ca/drugs/DB12500
Brand Name(s)
Not Available
Company Owner(s)
Impact Biomedicines Inc A Wholly Owned Sub Of Celgene Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tyrosine-protein kinase JAK2 | SINGLE PROTEIN | INHIBITOR | CHEMBL2971 |
Tyrosine-protein kinase receptor FLT3 | SINGLE PROTEIN | INHIBITOR | CHEMBL1974 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL263741 | |
PharmGKB | PA166280361 | |
Human Metabolome Database | HMDB0247668 | |
DrugBank | DB12500 | |
PubChem: Thomson Pharma | 26676801 | |
PubChem | 16722836 | |
LINCS | LSM-1142 | |
Nikkaji | J2.685.244G | |
PDBe | 2TA | |
BindingDB | 50332294 | |
EPA CompTox Dashboard | DTXSID90239483 | |
DrugCentral | 5347 | |
Brenda | 19117 | 154590 |
ChemicalBook | CB12485002 | |
Guide to Pharmacology | 5716 | |
rxnorm | FEDRATINIB HYDROCHLORIDE | FEDRATINIB |
PubChem: Drugs of the Future | 123055414 | |
ChEBI | 91408 | |
ZINC | ZINC000019862646 |